Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for plantar hyperhidrosis (100 vs 200 units)
jRCTs041210062Completed
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of botulinum toxin type A in plantar hyperhidrosis (2 arms). Primary endpoint: Primary responder rate at 4 weeks. Started Sep 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
plantar hyperhidrosis
Beyond the preview
Go deeper on jRCTs041210062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210062.